[Paramunization of FeLV-positive cats with PIND-AVI].
84 FeLV-positive cats were continually treated with the paramunity inducer (immunomodulator) PIND-AVI (23 healthy cats once a week, 61 diseased cats up to 3 times a week), the frequency depending on their general condition. The ELISA control tests were repeated after 4 to 6 weeks. Paramunization was continued in cats still viremic until remission of viremia. 21 healthy cats already reacted negatively to the first control ELISA, the 2 others after 8 weeks of paramunization. Within an observation time of 18 to 30 months there were no relapses. 49 of the 61 diseased cats (80.3%) reacted negatively to the first control. 5 cats (8.2%) had died at the beginning of the treatment. 5 cats (8.2%) showed a remission of viremic after being paramunized continually for 7 to 20 weeks. 2 cats (3.3%) remained viremic throughout the observation time (more than 2 years). None of the animals had a relapse. Neither had any of 9 chronically diseased cats, known to have been viremic for 3 to 12 months at the beginning of paramunization. The importance of the results of these paramunization tests for the treatment of various retrovirus infections of human beings and animals is briefly discussed.
Hörber
D
D
Kleintierpraxis D. Hörber, Dinkelsbühl.
Mayr
B
B
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D001688:Biological Products / Q000627:therapeutic use*; D002371:Cat Diseases / Q000628:therapy*; D002415:Cats; D004797:Enzyme-Linked Immunosorbent Assay; D007167:Immunotherapy; D007938:Leukemia / Q000628:therapy / Q000662:veterinary*; D005256:Leukemia Virus, Feline / Q000276:immunology*; D014766:Viremia / Q000628:therapy / Q000662:veterinary
D000276:Adjuvants, Immunologic; D000914:Antibodies, Viral; D001688:Biological Products; C028621:PIND-AVI
Paramunisierung FeLV-positiver Katzen mit PIND-AVI.